Journal of Biological Chemistry · 1999 · 300 citations · 33 references
Life SciencesBiochemistryPharmacologyCellular MetabolismMetabolismNatural Product BiosynthesisEicosanoid BiosynthesisLipid MetabolismArachidonic Acid MetabolitesCyclooxygenase IsoformsCyclooxygenase PathwaysEicosanoid Metabolic EnzymesProstaglandin D2 BiosynthesisProstaglandin E2 BiosynthesisProstaglandin H2 ConversionProstaglandin Production
The two cyclooxygenase isoforms, cyclooxygenase-1 and cyclooxygenase-2, both metabolize arachidonic acid to prostaglandin H2, which is subsequently processed by downstream enzymes to the various prostanoids. In the present study, we asked if the two isoforms differ in the profile of prostanoids that ultimately arise from their action on arachidonic acid. Resident peritoneal macrophages contained only cyclooxygenase-1 and synthesized (from either endogenous or exogenous arachidonic acid) a balance of four major prostanoids: prostacyclin, thromboxane A2, prostaglandin D2, and 12-hydroxyheptadecatrienoic acid. Prostaglandin E2 was a minor fifth product, although these cells efficiently converted exogenous prostaglandin H2 to prostaglandin E2. By contrast, induction of cyclooxygenase-2 with lipopol- ysaccharide resulted in the preferential production of prostacyclin and prostaglandin E2. This shift in product profile was accentuated if cyclooxygenase-1 was permanently inactivated with aspirin before cyclooxygenase-2 induction. The conversion of exogenous prostaglandin H2 to prostaglandin E2 was only modestly increased by lipopolysaccharide treatment. Thus, cyclooxygenase-2 induction leads to a shift in arachidonic acid metabolism from the production of several prostanoids with diverse effects as mediated by cyclooxygenase-1 to the preferential synthesis of two prostanoids, prostacyclin and prostaglandin E2, which evoke common effects at the cellular level. The two cyclooxygenase isoforms, cyclooxygenase-1 and cyclooxygenase-2, both metabolize arachidonic acid to prostaglandin H2, which is subsequently processed by downstream enzymes to the various prostanoids. In the present study, we asked if the two isoforms differ in the profile of prostanoids that ultimately arise from their action on arachidonic acid. Resident peritoneal macrophages contained only cyclooxygenase-1 and synthesized (from either endogenous or exogenous arachidonic acid) a balance of four major prostanoids: prostacyclin, thromboxane A2, prostaglandin D2, and 12-hydroxyheptadecatrienoic acid. Prostaglandin E2 was a minor fifth product, although these cells efficiently converted exogenous prostaglandin H2 to prostaglandin E2. By contrast, induction of cyclooxygenase-2 with lipopol- ysaccharide resulted in the preferential production of prostacyclin and prostaglandin E2. This shift in product profile was accentuated if cyclooxygenase-1 was permanently inactivated with aspirin before cyclooxygenase-2 induction. The conversion of exogenous prostaglandin H2 to prostaglandin E2 was only modestly increased by lipopolysaccharide treatment. Thus, cyclooxygenase-2 induction leads to a shift in arachidonic acid metabolism from the production of several prostanoids with diverse effects as mediated by cyclooxygenase-1 to the preferential synthesis of two prostanoids, prostacyclin and prostaglandin E2, which evoke common effects at the cellular level. prostaglandin arachidonic acid prostacyclin leukotriene cyclooxygenase hydroxyeicosatetraenoic acid 12-hydroxyheptadecatrienoic acid lipopolysaccharide peritoneal macrophage thromboxane phosphate-buffered saline acetylsalicylic acid tumor necrosis factor interleukin high pressure liquid chromatography enzyme immunoassay Prostaglandins (PGs)1are a family of intercellular and intracellular messengers derived from arachidonic acid (AA). These mediators exert a wide range of effects on processes such as smooth muscle tone, vascular permeability, cellular proliferation, and inflammatory/immune function. In many cases, different PGs will have opposing actions. For example, PGD2and thromboxane (TxA2) cause smooth muscle contraction, whereas PGE2 and prostacyclin (PGI2) cause relaxation (reviewed in Refs. 1Peters-Golden M. Lipscomb M. Russell S. Lung Macrophages and Dendritic Cells in Health and Disease. Marcel Dekker, Inc., New York1997: 151-182Google Scholar, 2Vane J. Bakhle Y. Botting R. Annu. Rev. Pharmacol. Toxicol. 1998; 38: 97-120Crossref PubMed Scopus (2620) Google Scholar, 3Dubois R.N. Abramson S.B. Crofford L. Gupta R.A. Simon L.S. Van De Putte L.B.A. Lipsky P.E. FASEB J. 1998; 12: 1063-1073Crossref PubMed Scopus (2231) Google Scholar, 4Bjorkman D. Am. J. Med. 1998; 105: 8S-12SAbstract Full Text Full Text PDF PubMed Scopus (75) Google Scholar). Similarly, TxA2increases, but PGI2 inhibits, platelet aggregation. The net effect evoked by PGs may, ultimately, depend on the balance of these opposing forces. The initial step in the synthesis of PGs from AA is mediated by cyclooxygenase (COX, also known as prostaglandin H synthase or prostaglandin endoperoxide synthase), of which two isoforms are recognized (reviewed in Refs. 2Vane J. Bakhle Y. Botting R. Annu. Rev. Pharmacol. Toxicol. 1998; 38: 97-120Crossref PubMed Scopus (2620) Google Scholar, 3Dubois R.N. Abramson S.B. Crofford L. Gupta R.A. Simon L.S. Van De Putte L.B.A. Lipsky P.E. FASEB J. 1998; 12: 1063-1073Crossref PubMed Scopus (2231) Google Scholar, 4Bjorkman D. Am. J. Med. 1998; 105: 8S-12SAbstract Full Text Full Text PDF PubMed Scopus (75) Google Scholar). COX-1 is expressed constitutively in most cell types, and prostanoids derived from COX-1 are thought to be important in gastric and renal homeostasis. COX-2, on the other hand, is the product of an immediate early gene and is rapidly expressed only after exposure of cells to hormones, mitogenic stimuli, and inflammatory mediators, like bacterial lipopolysaccharide (LPS). The induction of COX-2, with the resultant production of prostanoids, can contribute to parturition, inflammation, pain, fever, and certain types of cancer. The ability of aspirin to permanently inactivate both COX isoforms indiscriminately explains both its analgesic and anti-inflammatory properties, through COX-2 inhibition, as well as its damaging effects on the gastric mucosa, through COX-1 inhibition. Both COX isoforms convert AA to PGH2, which is then acted upon by discrete PG synthases to give rise to the different PG species. The current model for the regulation of PG synthesis posits that the amount of each PG is determined by the availability of the substrate AA (through the action of phospholipases A2) and by the total mass of COX protein present. According to this model, COX-2 induction results in more COX protein, more processing of AA to PGH2, and more of each type of PG. The profile of different PGs produced by a given cell type is thought to be determined primarily by the relative amounts of the distal PG synthases present in that cell type. In simple cases, as when a single distal enzyme predominates, this model may be accurate. However, when several different PG synthases exist in a single cell, the opportunity exists for COX-1 and COX-2 to selectively deliver PGH2 to different distal enzymes and thus produce different PGs. If so, then COX-2 induction and action could result in a shift in the profile of PGs, rather than simply an increase in total PG production. This could then change the integrated prostanoid signal that is delivered to target cells. In the current study, we used intact rat peritoneal macrophages (PMs) to compare the products derived from either COX-1 or COX-2 action on AA. These primary cells were chosen because they contain several PG synthases and would thus allow detection of selective metabolism of PGH2, if it existed. Freshly isolated PMs, which lack COX-2, provide an indication of the prostanoids that are derived from COX-1 action. By contrast, cells treated first with aspirin to permanently inactivate COX-1 and then with LPS to induce COX-2 demonstrate those prostanoids that are derived from COX-2. Our results indicate that AA metabolized by COX-1 gives rise to balanced amounts of PGI2, TxA2, PGD2, and 12-hydroxyheptadecatrienoic acid (HHT) as well as smaller amounts of PGE2, whereas COX-2 preferentially metabolizes AA to PGI2 and PGE2. Because PGI2 and PGE2 can evoke similar effects on target cells and tissues, the result of COX-2 induction may be a dramatic shift in the balance of PG action. Resident PMs were obtained by peritoneal lavage of specific pathogen-free, female Wistar rats (Charles River Laboratories, Portage, MI) as described previously (5Peters-Golden M. McNish R.W. Hyzy R. Shelly C. Toews G.B. J. Immunol. 1990; 144: 263-270PubMed Google Scholar). Lavaged cells were centrifuged at 600 × g for 5 min at 4 °C, resuspended, and subjected to hypotonic lysis to remove contaminating erythrocytes. Cells were then centrifuged again and resuspended at 0.5 × 106 cells ml−1 in M199 and either maintained in suspension in Teflon tubes (“freshly isolated cells”) or plated on 24-well plates (for metabolic studies) or glass slides (for imaging). Cells were incubated at 37 °C in a humidified atmosphere of 5% CO2 in air. As described previously (6Wilborn J. DeWitt D. Peters-Golden M. Am. J. Physiol. 1995; 268: L294-L301PubMed Google Scholar), cells were disrupted by sonication (10 bursts at 20% duty cycle) in ice-cold homogenizing buffer (50 mmTris-HCl, 25 mm KCl, 5 mm MgCl2, 1 mm dithiothreitol, 0.5 mm phenylmethylsulfonyl fluoride, 1 mm leupeptin, pH 7.4) and separated into soluble and pelletable fractions by centrifugation (100,000 ×g, 30 min, 4 °C); and protein concentrations were determined by a modified Coomassie Blue dye binding assay (Pierce). Samples containing 10 μg of protein were separated by SDS-polyacrylamide gel electrophoresis under reducing conditions and transferred to nitrocellulose membranes. Following blocking, membranes were probed with antibodies to COX-1 (rabbit polyclonal raised against sheep seminal vesicle COX (7Smith W. Rollins T. Methods Enzymol. 1982; 86: 213-222Crossref PubMed Scopus (22) Google Scholar)) and COX-2 (rabbit polyclonal raised against murine COX-2, from Cayman Chemical Co., Ann Arbor, MI; 1:10,000) and then peroxidase-conjugated goat anti-rabbit secondary antibody (1:5000) with ECL detection (Amersham Pharmacia Biotech). Cells were prepared for indirect immunofluorescent microscopy as described previously (8Brock T.G. Paine III, R. Peters-Golden M. J. Biol. Chem. 1994; 269: 22059-22066Abstract Full Text PDF PubMed Google Scholar). Following mounting on glass slides, cells were fixed using methanol (−20 °C, 30 min), permeabilized with acetone (−20 °C, 3 min), air-dried, rehydrated with sterile PBS, and blocked for 30 min using 0.1% (w/v) bovine serum albumin in PBS containing 1% (v/v) nonimmune goat serum. Preparations were then probed with antibodies to either COX-1 or COX-2, each at 1:200 in PBS supplemented with 0.1% fatty acid-free bovine serum albumin, followed by rhodamine-conjugated goat anti-rabbit antibody (1:200, Sigma). Preparations were examined and photographed using a Zeiss Aristoplan microscope equipped for epifluorescence. For overnight incubations, cells were adhered for 1 h, washed twice with sterile PBS, and cultured overnight in M199 containing 10% heat-inactivated newborn calf serum (Life Technologies, Inc.). In some experiments, aspirin (acetylsalicylic acid (ASA); 200 μm) was included during the 1 h adherence phase; this treatment did not affect cell adherence or survival, as determined by trypan blue staining and visualization of cells. During overnight incubation, some cells were cultured with LPS (1 μg/ml), TNF-α (100 ng/ml), IL-1 (5 ng/ml), or polymyxin B sulfate (10 For of cellular 0.5 of was included in the cell the was by with was with 1 for min at 37 during cell in included μm) and (1 of exogenous AA was by the of 0.5 of to cells during with the of AA did not of exogenous PGH2 was by the of (for or PGH2 (for enzyme immunoassay to cells during with were as described (5Peters-Golden M. McNish R.W. Hyzy R. Shelly C. Toews G.B. J. Immunol. 1990; 144: 263-270PubMed Google Scholar). were from using under resuspended in and separated by using a with a of acid. products were by their with and by immunoassay of was to the was by using Freshly isolated PMs were for the of the two COX By PMs contained COX-1 in fractions but COX-2 1 Similarly, but not COX-2, was in PMs by immunofluorescent microscopy 1 By this COX-1 to membranes the cell, membranes and the the profile of prostanoids synthesized by COX-1 isolated PMs were with for h, maintained in suspension in Teflon washed to remove the and with the (1 min, 37 to cellular AA from endogenous By this several products were after with of the AA converted to COX PGI2 as as PGE2, PGD2, and and metabolized to products of the This profile is similar to that previously (5Peters-Golden M. McNish R.W. Hyzy R. Shelly C. Toews G.B. J. Immunol. 1990; 144: 263-270PubMed Google Scholar). The production of prostanoids was by (1 a COX in in AA and but not the leukotriene and results from four that isolated PMs a balance of four prostanoids from endogenous PGI2, TxA2, PGD2, and PGE2 was a minor fifth product, for than 10% of COX-1 results were obtained when the AA was if of were to PMs in the of an then prostanoid similar to those by cells were produced of cells with in the of AA increased the synthesis of products but did not change the of the COX-1 products not from COX-1 in isolated endogenous exogenous were either with for h, and with (1 10 min, 37 or given exogenous h, 37 in were separated by results indicate the product as a of prostanoid are the of four is in in a Cells were either with for h, and with (1 10 min, 37 or given exogenous h, 37 in were separated by results indicate the product as a of prostanoid are the of four is in COX-2 induction in rat PMs was in to LPS (1 as two of and on By indirect immunofluorescent the of of COX-2 protein cells a treated with LPS for h 3 cells were for COX-2, some cells with COX-2 to the and and that COX-2 was on the and was also on the By it that cells staining for COX-2 were and whereas those staining the were and In experiments, cells trypan blue that the cells were not COX-2 protein was also to a by TNF-α (100 ng/ml), as a single 3 was induction by IL-1 (5 COX-1 was treatment with or IL-1 3 and it was not by overnight or the of and LPS treatment 3 on these on COX-2. According to current the result of mass of COX protein COX-2 induction be a increase in the synthesis of PGs that the given cell type can However, when PMs were treated with LPS for h to induce COX-2, and with (1 min, 37 to AA from cell selective in PG production were as with that in isolated cells. These PMs, which contained both COX-1 and COX-2, synthesized the products as isolated PMs However, LPS the of AA metabolized to PGE2 was whereas that converted to TxA2, as well as the product was for the PG profile LPS treatment would be that COX-2 preferentially metabolizes AA to PGI2 and PGE2, whereas the other prostanoids were derived from COX-1 action. COX-1 was inactivated in PMs with the was washed and COX-2 was with LPS for The treatment with μm) for 1 h COX and to remove in for h did not result in COX 4 The cells treated with that were washed and given LPS produced PGI2 and PGE2, as well as 4 These with only COX-2 of AA converted to PGs, as with in were only minor in production. the production of PGs was by the selective COX-2 in cells with and then given LPS to induce COX-2, PGE2 synthesis was by 1 as determined by with an of In contrast, in isolated PMs, of more than the of PGE2 synthesis was only by 30 the from that cells given LPS overnight and thus with both COX isoforms produced PGI2, and PGE2, with and This was also when the AA was of PMs with to inactivate COX-1 and thus COX-2 as the only LPS treatment resulted in PGI2 and PGE2 the major products of with in amounts In contrast, and were results were obtained if AA was and cells were not The two PGE2, of PGs COX-2, as with of PGs from cells containing only COX-1 PMs incubated overnight in with or polymyxin which and the profile of products as isolated PMs, that to be and with overnight not from given LPS for endogenous exogenous then given LPS for endogenous exogenous were adhered in with or μm) for 1 and incubated in with LPS (1 for h with Cells were then washed and with (1 10 min, 37 in were separated by results indicate the product as a of prostanoid are the of is in in a Cells were adhered in with or μm) for 1 and incubated in with LPS (1 for h with Cells were then washed and with (1 10 min, 37 in were separated by results indicate the product as a of prostanoid are the of is in for the PG profile LPS treatment would be that LPS selectively the amount or of enzymes that distal to the COX LPS have effects on PGI2 and PGE2 synthases and effects on synthases TxA2, PGD2, and this we examined the effects of LPS on the processing of the COX product, PGH2 μm) was efficiently metabolized to a of PGs by isolated PMs The most product was PGE2 at of This was because isolated PMs PGE2 from either endogenous AA or exogenous AA similar profile of products was obtained when PGH2 was given to cell not PMs were first treated with LPS for h, the of PGH2 converted to PGE2 increased from to of 5 with a increase in PGE2 synthase However, in using both cells and cell were isolated and PMs in the of products from The increase in PGE2 synthase was using to PGE2 production. Following to endogenous isolated PMs amounts of PGE2, and PGE2 production increased when PMs were treated with LPS for or h PGH2 was efficiently converted to PGE2 by isolated PMs, with the or h of LPS PGE2 production from PGH2 increased However, this although was only by These effects were to which also COX-2 synthesis in these cells The treatment of PMs with TNF-α for h also increased PGE2 synthesis from AA by whereas it increased PGE2 production from PGH2 again by only be that PGE2 production from PGH2, as in is on a different than PGE2 production from with the the In this study, we that isolated PMs, which have COX-1 but not COX-2, a balance of four major prostanoids from AA. fifth PGE2, is only a minor product, although these cells can convert PGH2 to PGE2. results were obtained if PMs were maintained overnight in In contrast, when PMs were incubated with LPS to induce COX-2, the profile of PG products to two PGs, PGI2 and PGE2. with to inactivate COX-2 as the only accentuated this These results were because COX mass through LPS treatment did not result in an increase in production of COX COX-2 induction a profile shift by preferential synthesis of PGI2 and PGE2 with production of PGD2, and shift in product profile may arise from a change in the amounts of each of the distal which the COX product, and M. S. PubMed Scopus Google Scholar, M. S. S. J. Immunol. 1998; Google have that PGE2 synthase was by LPS in inflammatory PMs, whereas synthase and synthase were In their cell from these cells this would to this step in the synthesis of PGE2. In this study, using PMs, we PGE2 synthase in both cells and cell before treatment with LPS as previously (6Wilborn J. DeWitt D. Peters-Golden M. Am. J. Physiol. 1995; 268: L294-L301PubMed Google Scholar). with LPS resulted in a but increase in PGE2 synthase This change may contribute to the increase in PGE2 production in cells. However, two results that in distal enzymes were not to for the change in PG the in product profile from distal enzymes were not to the in products derived from COX isoforms distal enzymes the of increase in PGE2 production from PGH2 was than that from AA The in for PGE2 synthesis from PGH2 in that the of not PGE2 is in the production of PGE2, and thus the in PGE2 synthase for the increased production of PGE2 LPS treatment. These results that other to the shift in product profile COX-2 induction. have that the COX-1 and COX-2 metabolic are at from in of when and the are expressed S. J. Biol. Chem. 1994; 269: Full Text PDF PubMed Google Scholar, J. S. W. S. 1994; PubMed Scopus Google Scholar, M. R. J. Biol. Chem. 1994; 269: Full Text PDF PubMed Google Scholar). However, we that the COX-1 and COX-2 differ in the profile of their model of this in PMs, on the results of this study, is given in According to this model, AA metabolism by COX-1 PGH2 that is in a balanced to enzymes that give rise to PGI2, TxA2, PGD2, and In contrast, COX-2 metabolism is more to the and enzymes than to other downstream the result of COX-2 induction by inflammatory mediators is not simply an increase in PGs that a given cell type can is a shift in the balance of PGs the preferential production of PGI2 and PGE2. simple for the shift in product profile to the of the metabolic the two COX isoforms to differ in their COX-1 is the intracellular whereas COX-2 is preferentially on and the M. T. DeWitt J. Biol. Chem. 1995; Full Text Full Text PDF PubMed Scopus Google Y. T. R. J. Immunol. Scholar). be that a this is or T. J. Biol. Chem. 1998; Full Text Full Text PDF PubMed Scopus Google Scholar), but results for the two isoforms also 1 and the different PG synthases to differ in their as T. Peters-Golden M. R. J. and Marcel Dekker, Inc., New York1997: Scholar). For example, the of synthase is in the of a of cell types M. Y. PubMed Scopus Google Scholar, Y. M. Y. J. Immunol. Google Scholar), whereas to the and D. 38: PubMed Scopus Google Scholar). different of by isoforms, may into the different COX M. R. Y. J. Biol. Chem. 1995; Full Text Full Text PDF PubMed Scopus Google Scholar, J. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). Thus, because of its may deliver PGH2 to downstream the other hand, COX-2 may AA from the by the action of the at that S. T. M. J. Biol. Chem. 1995; Full Text Full Text PDF PubMed Scopus Google Scholar, J. Biol. Chem. 1995; Full Text Full Text PDF PubMed Scopus Google Scholar, M. T. T. J. PubMed Scopus Google Scholar), and preferentially deliver PGH2 to distal enzymes on and the such as PGE2 synthase PGI2 The production of PGI2 and PGE2 is a common to inflammatory mediators in a wide range of Both PGI2 and PGE2 increased in vascular cells in to LPS or TNF-α R. W. J. R. J. Immunol. 1990; 144: Google Scholar), in cells in to LPS R. S. R. 1990; PubMed Scopus Google Scholar), in in to IL-1 or TNF-α T. J. PubMed Scopus Google Scholar), and in cells in to IL-1 or TNF-α R. M. J. Am. J. Immunol. PubMed Scopus Google Scholar). Similarly, PGE2 production by cells was in to antibodies and M. T. S. J. J. PubMed Scopus Google Scholar). the PGI2 and PGE2 in to IL-1 D. J. R. S. J. Biol. PubMed Scopus Google Scholar). In of PGI2 and PGE2 were when TNF-α was to rats J. J. M. S. C. PubMed Scopus Google or sheep W. Am. Rev. PubMed Scopus Google and also when was given to D. S. Am. Rev. PubMed Scopus Google Scholar). Because COX-2 induction is common to these these results are with the that COX-2 preferentially metabolizes AA to PGI2 and PGE2. is the of the production of PGI2 and Both PGs evoke a of common cellular smooth muscle and smooth muscle proliferation, and function. other are also both PGs evoke many of these effects through of (reviewed in Refs. W. Am. Rev. PubMed Scopus Google and D. S. Am. Rev. PubMed Scopus Google Scholar). through both PGI2 and PGE2 of many and some (reviewed in Refs. R. S. R. Immunol. 12: Full Text PDF PubMed Scopus Google and S. S. Scholar). Thus, PGI2 and production by in of and TNF-α M. J. Immunol. Google Scholar, D. R. Med. Biol. PubMed Google Scholar). through effects on and thus these PGs may either have effect or increase the production of and C. R. M. J. Immunol. 1995; PubMed Scopus Google Scholar). These results that the induction of COX-2 may, by the profile of PG to the inflammatory in some Thus, in the of inflammatory mediators, COX-1 to a balance of PGs that may a of homeostasis. mediators, like bacterial would evoke a of the synthesis of and COX-2. Our as well as the indicate that COX-2 metabolism of AA will the balance of PGs to PGI2 and PGE2. these PGs would subsequently the of the inflammatory through the of the synthesis of at the of a profile of According to this model, a in the ability to induce COX-2 would both the synthesis of PGI2 and PGE2 and in some from with have a to COX-2, but not and PGE2 than J. Crofford L. M. S. R. Peters-Golden M. J. 1995; PubMed Scopus Google Scholar). The to induce COX-2 and produce prostanoids that can inflammation, proliferation, and synthesis can thus contribute to
33
Cyclooxygenase in biology and disease
Raymond N. DuBois, Steven B. Abramson, Leslie J. Crofford et al. · The FASEB Journal · 1998 · 2.5K citations